Cointime

Thermogenesis

company

About

Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.

  • 51 - 100

Highlights

Total Funding Amount
$250K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$250K
Industries
Biotechnology,Health Care,Medical,Medical Device,Therapeutics
Founded date
Jan 1, 1986
Number Of Employee
51 - 100
Operating Status
Active

Thermogenesis is a health care company that focuses in development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. It is a supplier of enabling technologies for the processing and storage of stem cells and biological tissues. The company was founded by David Demirjian and Philip Coelho.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$250K
Thermogenesis has raised a total of $250K in funding over 2 rounds. Their latest funding was raised on Sep 14, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 14, 2021 Grant $250K 1 National Institutes of Health (NIH) — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Thermogenesis is funded by 1 investors. National Institutes of Health (NIH) are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health (NIH) Yes Grant
Cointime
İçerikler
Şirket.